Nektar Therapeutics Annual Shareholders Meeting Transcript
Hello. I would like to welcome everyone to the 2026 Annual Meeting of Stockholders of Nektar Therapeutics. My name is Elizabeth Zhang, Vice President, Legal and Corporate Counsel at Nektar. It is my pleasure to host the 2026 Annual Meeting. I will serve as Secretary of the meeting. I am joined today with Howard Robin, our President and CEO; and members of our Board of Directors and the Nektar executive team. Representatives of Ernst & Young, our independent auditors, are also with us.
We will now turn to the formal business portion of Agenda. When that is complete, I will turn the meeting over to Howard Robin to provide an overview of business highlights from the past year, and then we will open the floor for stockholder questions.
The 2026 Annual Meeting of the Stockholders of Nektar Therapeutics will now officially come to order.
I have at this meeting a complete list of the stockholders of record of the company's common stock on April 6, 2026, the record date for this meeting. I also have
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

